An antioxidant and anti-aging sturgeon roe tetrapeptide, its preparation method and application

By preparing sturgeon roe tetrapeptide KYPL with the amino acid sequence Lys-Tyr-Pro-Leu, the problems of lipid peroxidation and organism survival protection lacking in existing sturgeon roe active peptides have been solved, achieving significant antioxidant and anti-aging effects.

CN123106818APending Publication Date: 2026-11-17SOUTH CHINA UNIV OF TECH
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202611619986.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-20
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing technologies lack technical solutions and applications for sturgeon roe active peptides that provide dual protection against lipid peroxidation and organism survival rate.

Method used

An antioxidant and anti-aging sturgeon roe tetrapeptide KYPL with the amino acid sequence Lys-Tyr-Pro-Leu was prepared by enzymatic hydrolysis and Fmoc solid-phase synthesis. The peptide was purified by ultrafiltration, chromatographic separation and mass spectrometry identification, and then combined with pharmaceutically, food-, and cosmetically acceptable carriers or excipients to prepare an antioxidant composition.

Benefits of technology

KYPL showed no significant toxicity to HaCaT cells in the range of 0.05–0.1 mg/mL, but significantly increased the activity of SOD, CAT, and GSH-Px, reduced MDA content, and prolonged the survival rate of organisms in H2O2 stress and natural aging models.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106818A_ABST
    Figure CN123106818A_ABST
Patent Text Reader

Abstract

This invention discloses an antioxidant and anti-aging sturgeon roe tetrapeptide, its preparation method, and its application, belonging to the field of bioactive peptide technology. The amino acid sequence of this antioxidant and anti-aging sturgeon roe tetrapeptide is KYPL. The preparation method is as follows: enzymatic hydrolysis: (1) add deionized water to sturgeon roe and homogenize; (2) adjust the pH value, add alkaline protease, hydrolyze, inactivate the enzyme, and cool; (3) centrifuge and take the supernatant to obtain the product. Alternatively, Fmoc solid-phase synthesis method is used: Leu, Pro, Tyr, and Lys are coupled sequentially from the C-terminus to the N-terminus, followed by lysis, deprotection, purification, and freeze-drying to obtain the product. The antioxidant and anti-aging sturgeon roe tetrapeptide KYPL of this invention has antioxidant and / or anti-aging activities and can be used to prepare antioxidant and anti-aging drugs, foods (especially health foods and special dietary foods), or cosmetics.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of bioactive peptide technology, and more specifically to an antioxidant and anti-aging sturgeon roe tetrapeptide, its preparation method, and its application. Background Technology

[0002] Oxidative stress is a major driver of aging in the body and skin. Excessive accumulation of reactive oxygen species can deplete endogenous antioxidant defense systems such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), and generate end products such as malondialdehyde (MDA) through lipid peroxidation, further damaging cell membranes, proteins, and the extracellular matrix, ultimately resulting in decreased cell function, weakened tissue repair capacity, and accelerated aging.

[0003] Food-derived small molecule peptides, characterized by low molecular weight, well-defined structure, easy compatibility, and high safety, represent an important direction for the development of antioxidant and anti-aging functional factors. Aquatic protein resources, after enzymatic hydrolysis, can release various bioactive peptides with functions such as free radical scavenging, metal ion chelation, cell membrane protection, or extracellular matrix support. Among these, sturgeon roe protein is high in protein, providing a resource base for developing high-value-added functional peptides.

[0004] Therefore, how to develop an antioxidant and anti-aging sturgeon roe peptide is a problem that urgently needs to be solved by those skilled in the art. Summary of the Invention

[0005] In view of this, the purpose of this invention is to provide an antioxidant and anti-aging sturgeon roe tetrapeptide, its preparation method and application, so as to solve the problem that there is no technical solution and application for dual protection against lipid peroxidation and body survival rate in the existing sturgeon roe active peptides.

[0006] To achieve the above objectives, the present invention adopts the following technical solution:

[0007] An antioxidant and anti-aging sturgeon roe tetrapeptide with the amino acid sequence Lys-Tyr-Pro-Leu, abbreviated as KYPL (as shown in SEQ ID NO:1).

[0008] The antioxidant and anti-aging sturgeon roe tetrapeptide KYPL of this invention has lysine (Lys) at the N-terminus, tyrosine (Tyr) at the second position, proline (Pro) at the third position, and leucine (Leu) at the C-terminus. It has a theoretical average relative molecular mass of 519.63 Da and exhibits antioxidant and / or anti-aging activities.

[0009] A method for preparing the above-mentioned antioxidant and anti-aging sturgeon roe tetrapeptide employs an enzymatic hydrolysis method (alkaline protease hydrolysis process). The method involves obtaining the sturgeon roe protease hydrolysis product through ultrafiltration, chromatographic separation, mass spectrometry identification, and purification. The target peptide fragment is confirmed by LC-MS / MS. The specific steps include: (1) Add deionized water to sturgeon roe and homogenize to obtain sturgeon roe homogenate; (2) Adjust the pH of the sturgeon roe homogenate, add alkaline protease, hydrolyze, inactivate the enzyme, cool, and obtain sturgeon roe hydrolysate; (3) Centrifuge the sturgeon roe enzymatic hydrolysate, take the supernatant, and obtain the antioxidant and anti-aging sturgeon roe tetrapeptide with the amino acid sequence KYPL, and store it for later use.

[0010] Furthermore, in step (1) above, the mass ratio of sturgeon roe to deionized water is 1:6; the homogenization speed is 8000 rpm and the time is 1 min.

[0011] Furthermore, in step (2) above, the amount of alkaline protease added is 1%; the enzymatic hydrolysis temperature is 55℃ and the time is 8h; the enzyme inactivation temperature is 95℃ and the time is 12min; and the enzyme is cooled to room temperature.

[0012] Furthermore, in step (3) above, the centrifugation temperature is 4℃, the rotation speed is 8000rpm, and the time is 15min; the storage temperature is -80℃.

[0013] A method for preparing the above-mentioned antioxidant and anti-aging sturgeon roe tetrapeptide, using the Fmoc solid-phase synthesis method, specifically includes the following steps: sequentially coupling Leu, Pro, Tyr and Lys from the C-terminus to the N-terminus, followed by cleavage, deprotection, purification and freeze-drying to obtain the antioxidant and anti-aging sturgeon roe tetrapeptide with the amino acid sequence KYPL, which is then stored for later use.

[0014] Furthermore, the Tyr was prepared using Fmoc-Tyr(tBu)-OH with side-chain protection; the Lys was prepared using Fmoc-Lys(Boc)-OH with side-chain protection; the purification was carried out by reversed-phase high-performance liquid chromatography, and the target molecular weight was confirmed by mass spectrometry.

[0015] An antioxidant and anti-aging composition comprising the above-mentioned antioxidant and anti-aging sturgeon roe tetrapeptide or its pharmaceutically, food-grade, or cosmetically acceptable salt as an active ingredient, and a pharmaceutically, food-grade, or cosmetically acceptable carrier or excipient; the antioxidant and anti-aging composition is a drug, food (especially health food, special dietary food) or cosmetic.

[0016] This invention also claims protection for the use of the above-mentioned antioxidant and anti-aging sturgeon roe tetrapeptide in the preparation of products that resist oxidation or delay oxidative stress-related damage.

[0017] Furthermore, the aforementioned antioxidants include increasing the activity of one or more of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), and / or reducing malondialdehyde (MDA) content; delaying oxidative stress-related damage, including H2O2-induced cellular oxidative damage, and / or H2O2-induced nematode oxidative stress damage; and the products are pharmaceuticals, foods (especially health foods and special dietary foods), or cosmetics.

[0018] This invention also claims protection for the use of the above-mentioned antioxidant and anti-aging sturgeon roe tetrapeptide in the preparation of products that delay aging.

[0019] Furthermore, the aforementioned methods of delaying aging include improving the survival rate of organisms in natural aging models, delaying the decline in the survival rate of organisms in natural aging models, or extending their survival time during the natural aging process; the products are drugs, foods (especially health foods and special dietary foods), or cosmetics.

[0020] The effective concentration of the antioxidant and anti-aging sturgeon roe tetrapeptide of this invention is 0.05~0.1 mg / mL in the cell experiment system and 0.5~2.0 mg / mL in the nematode experiment system.

[0021] As can be seen from the above technical solution, compared with the prior art, the beneficial effects of the present invention are as follows: (1) KYPL showed no significant toxicity to HaCaT cells in the range of 0.05~0.1 mg / mL; (2) 0.1 mg / mL KYPL increased the activities of SOD, CAT and GSH-Px in H2O2-damaged HaCaT cells by 76.5%, 82.0% and 109.7% respectively compared with the model group, and reduced the MDA content by 36.3% compared with the model group; (3) At a concentration of 0.1 mg / mL, the MDA level of KYPL was lower than that of NLPL and sturgeon roe peptide SRP, showing a stronger ability to inhibit lipid peroxidation. (4) At the cellular and model organism level, KYPL can improve the survival rate of H2O2-stressed nematodes and naturally aging nematodes.

[0022] In summary, the antioxidant and anti-aging sturgeon roe tetrapeptide KYPL of this invention can be used to prepare antioxidant and anti-aging drugs, foods (especially health foods and special dietary foods) or cosmetics. Attached Figure Description

[0023] Figure 1 Survival rates of each experimental group in the H2O2-stressed nematode model; Figure 2 Survival rates of KYPL at different concentrations in a naturally aging nematode model; Figure 3 The survival rate of high concentrations of sturgeon roe peptides SRP, NLPL, and KYPL in a naturally aging nematode model was determined. Detailed Implementation

[0024] The technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0025] Example 1: Preparation and Structure of KYPL The preparation method of the antioxidant and anti-aging sturgeon roe tetrapeptide adopts an enzymatic hydrolysis method (alkaline protease hydrolysis process), which specifically includes the following steps: (1) Add 6 times the mass of deionized water to sturgeon roe and homogenize at 8000 rpm for 1 min to obtain sturgeon roe homogenate. (2) Adjust the sturgeon roe homogenate to the optimal pH value, add 1% alkaline protease, place it in a constant temperature shaker and enzymatically hydrolyze it at 55℃ for 8 hours, then place it in a boiling water bath and inactivate the enzyme at 90℃ for 15 minutes, cool it to room temperature, and obtain sturgeon roe hydrolysate. (3) Centrifuge the sturgeon roe enzymatic hydrolysate at 4℃ and 8000rpm for 15min, and take the supernatant, which is the sturgeon roe enzymatic hydrolysate. (4) The sturgeon roe protein hydrolysate was subjected to ultrafiltration, chromatographic separation, mass spectrometry identification and purification. The target peptide was confirmed by LC-MS / MS to obtain the antioxidant and anti-aging sturgeon roe tetrapeptide with the amino acid sequence KYPL. It was stored at -80℃ for later use.

[0026] Alternatively, the preparation method of the antioxidant and anti-aging sturgeon roe tetrapeptide, using the Fmoc solid-phase synthesis method, specifically includes the following steps: (1) Using a solid resin loaded with Fmoc-Leu-OH as the starting support, Fmoc protecting groups were removed by using 20% ​​piperidine / DMF; Fmoc-Pro-OH, Fmoc-Tyr(tBu)-OH and Fmoc-Lys(Boc)-OH were sequentially coupled in DMF using HBTU / HOBt / DIPEA as the condensation system; washing and ninhydrin detection were performed after each coupling step; after synthesis, lysis and side chain deprotection were performed using a lysis buffer with a TFA / TIS / H2O volume ratio of 95:2.5:2.5, precipitated with ice-cold diethyl ether, and the crude peptide was collected by centrifugation; (2) The crude peptide was purified by reversed-phase high-performance liquid chromatography. The chromatographic column was a C18 column and the mobile phase was a water-acetonitrile system containing 0.1% trifluoroacetic acid. The target peak was collected and then freeze-dried. (3) The molecular weight of the target peptide was confirmed by mass spectrometry. The theoretical average relative molecular mass of KYPL is 519.63 Da, the relative molecular mass of a single isotope is about 519.31 Da, and the amino acid sequence is Lys-Tyr-Pro-Leu, abbreviated as KYPL (as shown in SEQ ID NO:1).

[0027] Existing technology CN117384245A discloses an antioxidant and anti-aging sturgeon roe tetrapeptide, its preparation method, and its applications. Its claims revolve around the Asn-Leu-Pro-Leu sequence (abbreviated as NLPL, as shown in SEQ ID NO:2), the alkaline protease hydrolysis process of sturgeon roe, and the anti-aging uses of NLPL. However, this patent does not disclose the application of Lys-Tyr-Pro-Leu (KYPL) in antioxidant and nematode aging models, nor does it provide any technical inspiration for KYPL relative to NLPL in terms of lipid peroxidation inhibition, stress survival protection, or maintenance of survival rate during natural aging.

[0028] The sequence characteristics of KYPL and the control peptide NLPL are shown in Table 1. The theoretical average relative molecular mass of KYPL is calculated based on the free N-terminus and free C-terminus tetrapeptides.

[0029] Table 1 Comparison of characteristic sequences of KYPL and NLPL

[0030] As shown in Table 1, although KYPL and NLPL both belong to the tetrapeptide derived from sturgeon roe, their first and second amino acids differ. Specifically, the sequence of NLPL is Asn-Leu-Pro-Leu, while the sequence of KYPL is Lys-Tyr-Pro-Leu. In KYPL, Lys imparts an N-terminal basicity, Tyr introduces a phenolic hydroxyl group with hydrogen-donating ability, Pro provides a rigid turn, and Leu provides a hydrophobic side chain. These structural differences enable KYPL to simultaneously possess the functions of directly scavenging free radicals, maintaining antioxidant enzyme activity, and inhibiting the lipid peroxidation chain reaction.

[0031] Compared to NLPL, KYPL's innovation lies not only in the difference in the arrangement of its four amino acids, but also in the different physicochemical and functional combinations formed by the introduction of Lys and Tyr. Specifically, the Lys side-chain amino group facilitates interaction with acidic environments or metal ions, the Tyr phenolic hydroxyl group acts as a hydrogen donor to block free radical chain reactions, and the rigid hydrophobic unit composed of Pro and Leu helps maintain the peptide conformation and proximity to membrane oxidation sites. Experimental results show that this structural combination corresponds to KYPL's advantages in malondialdehyde (MDA) inhibition and nematode stress survival protection.

[0032] Example 2: Effect of KYPL on HaCaT cell viability Immortalized human skin keratinocytes (HaCaT) were cultured in DMEM complete medium containing 10% fetal bovine serum and 1% penicillin-streptomycin at 37°C and 5% CO2. Logarithmic growth phase cells were harvested and cultured at 100 μL per well using 1×10⁶ cells / well. 5 Cells were seeded in 96-well plates, with three replicates per group. Four groups were established: a normal group, a sturgeon roe peptide SRP group, an NLPL group, and a KYPL group. After 24 h of incubation, except for the normal group, the other experimental groups were added to fresh culture medium containing 0.5 mg / mL or 1.0 mg / mL of sturgeon roe protease hydrolysate (sturgeon roe peptide SRP) prepared by enzymatic hydrolysis in Example 1, or 0.05 mg / mL or 0.1 mg / mL of NLPL or KYPL, and incubated for another 48 h. After incubation with CCK-8 solution for 2 h, the absorbance at 450 nm was measured. Relative cell viability was calculated using the formula: Relative cell viability (%) = OD of sample group / OD of normal group × 100%.

[0033] The results are shown in Table 2.

[0034] Table 2. Relative cell viability of HaCaT cells in each experimental group

[0035] Table 2 shows that the relative cell viability was greater than 90% after treatment with each test substance. Specifically, the relative cell viability of SRP at 0.5 and 1.0 mg / mL was 98.37±0.65% and 96.65±1.58%, respectively; that of NLPL at 0.05 and 0.1 mg / mL was 98.99±1.44% and 97.78±1.98%, respectively; and that of KYPL at 0.05 and 0.1 mg / mL was 93.54±1.39% and 99.77±1.04%, respectively. This indicates that KYPL had no significant toxicity to HaCaT cells in the range of 0.05–0.1 mg / mL.

[0036] Example 3: Effects of KYPL on H2O2-damaged HaCaT cell viability and antioxidant indices HaCaT cells in the logarithmic growth phase were harvested at a concentration of 1×10⁻⁶. 5 1 × 10⁶ cells / mL were inoculated into 96-well plates, with 3 replicates per group. The following groups were established: normal control (NC), model (MC), sturgeon roe peptide (SRP), NLPL, and KYPL. 1 × 10⁶ cells / mL were added to the MC and test substance groups. -3Induced with mol / L H2O2 for 2 h, washed with PBS, and then cultured for 48 h in complete medium containing 0.5 mg / mL or 1.0 mg / mL SRP, or 0.05 mg / mL or 0.1 mg / mL NLPL or KYPL respectively. (1) After incubation with CCK-8 solution for 2 h, the absorbance at 450 nm was measured. Cell viability was calculated using the formula: Cell viability (%) = OD sample group / OD normal group × 100%. (2) After H2O2 induction stimulation and sample treatment of cells as described above, cells were collected, washed with PBS, lysed, and the supernatant was collected. The activities of SOD, CAT, GSH-Px and the content of MDA were measured according to the kit instructions.

[0037] The relative viability of HaCaT cells damaged by H2O2 is shown in Table 3.

[0038] Table 3. Effects of H2O2-induced HaCaT cell viability on the results of each experimental group.

[0039] Table 3 shows that, compared with the normal group, the relative cell viability in the model group decreased to 47.09±1.92%, indicating that the H2O2 oxidative damage model was successfully established. After KYPL intervention, cell viability rebounded in a dose-dependent manner. The cell viability in the 0.05 mg / mL KYPL groups was 61.38±1.02% and 77.56±1.78%, respectively, which were 30.4% and 64.7% higher than those in the model group. At a dose of 0.1 mg / mL, the cell viability in the KYPL group was higher than that in the NLPL-0.1 group (72.80±1.44%) and the SRP-1.0 group (66.22±3.65%).

[0040] The results of the antioxidant index are shown in Table 4.

[0041] Table 4. SOD, CAT, GSH-Px and MDA indices for each experimental group

[0042] Note: Compared with the normal group, ### means p < 0.001; compared with the model group, For p < 0.05, For p < 0.01, For example, p < 0.001; compared with the SRP-1.0 group, p < 0.001; compared with NLPL-0.1, p < 0.05.

[0043] Table 4 shows that compared with the normal group, the activities of SOD, CAT, and GSH-Px in the model group were significantly reduced, while the content of MDA was significantly increased, confirming the oxidative damage model. After KYPL intervention, all indicators improved in a dose-dependent manner. In the KYPL-0.1 group, SOD activity was 35.46±2.45 U / mg prot, recovering to 87.6% of the normal group; CAT activity was 27.53±0.49 U / mg prot, recovering to 85.5% of the normal group; GSH-Px activity was 28.35±1.76 U / mg prot, recovering to 83.2% of the normal group; and MDA content decreased to 2.69±0.18 nmol / mg prot, close to the level of the normal group. Compared with the model group, the activities of SOD, CAT, and GSH-Px in the KYPL-0.1 group increased by 76.5%, 82.0%, and 109.7%, respectively, while the MDA content decreased by 36.3%, all of which were statistically significant (P<0.01).

[0044] Intergroup comparisons showed that the MDA content in the KYPL-0.1 group was lower than that in the NLPL-0.1 group (2.69 vs. 3.00 nmol / mg prot) and the SRP-1.0 group (2.69 vs. 3.20 nmol / mg prot), decreasing by 10.3% and 15.9%, respectively. The activities of SOD, CAT, and GSH-Px were also higher in the KYPL group at the same dose than in the NLPL-0.1 and SRP-1.0 groups. At a dose of 0.05 mg / mL, the SOD and GSH-Px activities in the KYPL group were increased by 9.9% and 15.5%, respectively, compared to the NLPL-0.05 group. These results indicate that KYPL effectively restores the activity of antioxidant enzymes while exhibiting a more significant inhibitory effect on the lipid peroxidation end product MDA.

[0045] Example 4: Effect of KYPL on the survival rate of H2O2-stressed nematodes A stress-induced aging model of *C. elegans* induced by H2O2 was established: L4 stage N2 wild-type nematodes were selected, and eggs were obtained after synchronization with lysis buffer. These eggs were incubated under the same conditions until the nematodes reached the L4 stage, then transferred to a 20℃ incubator for further culture. 30% H2O2 solution was added to NGM medium to a final concentration of 5 mmol / L, and the nematodes were then transferred to this medium for 2 h. After washing with PBS, each group was transferred to normal NGM medium containing the corresponding test substance. Sturgeon roe peptide, NLPL, KYPL, and *E. coli* OP50 were mixed. The experiment consisted of a blank control group, a model group (H2O2, MC), a sturgeon roe peptide SRP-1 group (1 mg / mL), a sturgeon roe peptide SRP-2 group (2 mg / mL), an NLPL-1 group (1 mg / mL), an NLPL-2 group (2 mg / mL), a KYPL-1 group (1 mg / mL), and a KYPL-2 group (2 mg / mL). Except for the blank control group, all other groups underwent H2O2 treatment to induce modeling. L4-stage synchronized nematodes were randomly divided into groups of 30 nematodes each and placed in the aforementioned culture media. The culture medium was replaced with fresh medium every 24 h, and the nematodes were continuously cultured at 20℃. The time when the nematodes were transferred to the drug-treated plate was recorded as day 0. The survival status of the nematodes was recorded at set time points (days 0, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 10, 11, and 12) until all nematodes died, at which point the experiment ended. The nematode survival rate was calculated. The criterion for determining death was to gently touch the nematode's body with a platinum wire needle; if there was no reaction, it was considered dead.

[0046] See results Figure 1 See Table 5.

[0047] Table 5. Survival rates of each experimental group in the H2O2 stress nematode model.

[0048] Depend on Figure 1As shown in Table 5, the survival rate of the model group gradually decreased with stress duration, reaching 0 at 11 days. The survival rates of the KYPL-1 and KYPL-2 groups were higher than those of the model group in the later stages of stress. At 7.5 days, the survival rate of the model group was 10.47%, while that of the KYPL-1 and KYPL-2 groups was 29.41% and 32.35%, respectively, which were 2.81 times and 3.09 times that of the model group. At 10 days, the KYPL-1 and KYPL-2 groups still maintained survival rates of 2.94% and 5.88%, respectively; the KYPL-2 group still had a 2.63% survival rate at 11 days, while the model group, SRP-1 group, SRP-2 group, NLPL-1 group, and NLPL-2 group all reached 0 at 11 days, indicating that KYPL-2 can significantly prolong the survival time of nematodes under H2O2 stress. Compared with the model group, both the KYPL-1 and KYPL-2 groups showed higher survival rates in the middle and late stages of stress. The KYPL-2 group had higher survival rates at 7.5 days, 10 days, and 11 days than the NLPL-2 group at the same dose (7.5 days: 32.35% vs. 18.75%; 10 days: 5.88% vs. 3.75%), indicating that KYPL has a better protective effect against nematodes under H2O2 stress.

[0049] Example 5: Effect of KYPL on the survival rate of naturally aging nematodes A natural aging model of *Caenorhabditis elegans* was established: L4-stage N2 wild-type nematodes were selected, and eggs were obtained after synchronization with lysis buffer. Eggs were incubated under the same conditions until the nematodes reached the L4 stage, then transferred to a 20 ℃ constant temperature incubator for further culture and subsequent experiments. A normal group (NC), a sturgeon roe peptide (SRP) group, a NLPL group, and a KYPL group were set up. The normal group was cultured in a drug-free medium, while the test groups were prepared with nematode culture media containing sturgeon roe peptide (SRP) (2.0 mg / mL), NLPL (2.0 mg / mL), and KYPL (0.5, 1.0, and 2.0 mg / mL), respectively. L4-stage synchronized nematodes were randomly divided into groups of 30 nematodes each and placed in the aforementioned culture media. Fresh culture medium was added every 24 h, and the nematodes were continuously cultured at 20 ℃. The time when the nematodes were transferred to the drug-treated plate was recorded as day 0. Nematode survival was recorded at set time points until all nematodes died, at which point the experiment ended, and the nematode survival rate was calculated. The criterion for determining death is to gently touch the nematode's body with a platinum wire needle; if there is no reaction, it can be determined as dead.

[0050] See results Figure 2-3 See Table 6.

[0051] Table 6. Survival rates of each experimental group in the naturally aging nematode model.

[0052] Depend on Figure 2-3 As shown in Table 6, the survival rate of the normal group was 60.00% on day 21, decreasing to 15.00% on day 25, 10.00% on day 28, and 0% on day 29. The survival rates of the KYPL-2.0 group on days 21, 25, 28, and 30 were 74.81%, 57.41%, 42.96%, and 31.85%, respectively, all higher than the normal group; the survival rates on days 25 and 28 were 3.83 times and 4.30 times that of the normal group, respectively. Compared with the NLPL-2.0 group, the survival rates of the KYPL-2.0 group on days 25, 28, and 30 were increased by 10.74%, 6.29%, and 9.35%, respectively, showing a greater advantage in maintaining survival in the later stages of natural aging. Furthermore, the KYPL dosage groups showed a certain dose-dependent trend, with the KYPL-2.0 group having a higher survival rate at all time points than the KYPL-1.0 and KYPL-0.5 groups.

[0053] Example 7 Composition and Application By mixing KYPL with pharmaceutically acceptable carriers or excipients, pharmaceutical compositions for anti-oxidation or anti-aging can be prepared. These carriers or excipients include, but are not limited to, fillers, disintegrants, binders, lubricants, emulsifiers, solubilizers, stabilizers, and preservatives. Dosage forms include, but are not limited to, tablets, capsules, granules, oral liquids, powders, injections, or topical preparations.

[0054] By mixing KYPL with food-grade acceptable ingredients or excipients, antioxidant or anti-aging foods (especially health foods and special dietary foods) can be prepared. These foods can take various forms, including but not limited to solid beverages, compressed candies, capsules, drinks, nutritional powders, or functional food ingredients.

[0055] By combining KYPL with cosmetically acceptable raw materials or excipients, cosmetics with antioxidant or anti-aging properties can be prepared. These cosmetic forms include, but are not limited to, serums, lotions, creams, masks, gels, sprays, or lyophilized powders. KYPL can be used as a single active peptide or in combination with other raw materials possessing moisturizing, repairing, or antioxidant properties.

[0056] The above description of the disclosed embodiments enables those skilled in the art to make or use the invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the invention is not to be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. An antioxidant and anti-aging sturgeon caviar tetrapeptide, characterized in that, The amino acid sequence is KYPL.

2. A method for preparing the antioxidant and anti-aging sturgeon roe tetrapeptide as described in claim 1, characterized in that, The enzymatic hydrolysis method includes the following steps: (1) Add deionized water to sturgeon roe and homogenize to obtain sturgeon roe homogenate; (2) Adjust the pH of the sturgeon roe homogenate, add alkaline protease, hydrolyze, inactivate the enzyme, cool, and obtain sturgeon roe hydrolysate; (3) Centrifuge the sturgeon roe enzymatic hydrolysate, take the supernatant, and obtain the antioxidant and anti-aging sturgeon roe tetrapeptide with the amino acid sequence KYPL, and store it for later use.

3. The method for preparing an antioxidant and anti-aging sturgeon roe tetrapeptide according to claim 2, characterized in that, In step (1), the mass ratio of sturgeon roe to deionized water is 1:6; the homogenization speed is 8000 rpm and the time is 1 min; In step (2), the amount of alkaline protease added is 1%; the enzymatic hydrolysis temperature is 55℃ and the time is 8h; the enzyme inactivation temperature is 95℃ and the time is 12min; and the enzyme is cooled to room temperature. In step (3), the centrifugation process is carried out at a temperature of 4°C, a rotation speed of 8000 rpm, and a time of 15 min; the storage temperature is -80°C.

4. A method for preparing the antioxidant and anti-aging sturgeon roe tetrapeptide as described in claim 1, characterized in that, The Fmoc solid-phase synthesis method includes the following steps: Leu, Pro, Tyr and Lys are coupled sequentially from C-terminus to N-terminus, followed by cleavage, deprotection, purification and freeze-drying to obtain the antioxidant and anti-aging sturgeon roe tetrapeptide with the amino acid sequence KYPL, which is then stored for later use.

5. The method for preparing an antioxidant and anti-aging sturgeon roe tetrapeptide according to claim 4, characterized in that, The Tyr is Fmoc-Tyr(tBu)-OH with side-chain protection; the Lys is Fmoc-Lys(Boc)-OH with side-chain protection; the purification is performed by reversed-phase high-performance liquid chromatography, and the target molecular weight is confirmed by mass spectrometry.

6. An antioxidant and anti-aging composition, characterized in that, Contains as an active ingredient the antioxidant and anti-aging sturgeon roe tetrapeptide as described in claim 1 or its pharmaceutically, food-, or cosmetically acceptable salt, as well as a pharmaceutically, food-, or cosmetically acceptable carrier or excipient. The antioxidant and anti-aging composition is a drug, food, or cosmetic.

7. The use of the antioxidant and anti-aging sturgeon roe tetrapeptide as described in claim 1 in the preparation of products that resist oxidation or delay oxidative stress-related damage.

8. The application according to claim 7, characterized in that, The antioxidants include increasing the activity of one or more of superoxide dismutase, catalase and glutathione peroxidase, and / or reducing malondialdehyde content. The delayed oxidative stress-related damage includes H2O2-induced cellular oxidative damage and / or H2O2-induced nematode oxidative stress damage. The product in question is a drug, food, or cosmetic.

9. The application of the antioxidant and anti-aging sturgeon roe tetrapeptide as described in claim 1 in the preparation of products that delay aging.

10. The application according to claim 9, characterized in that, The aforementioned delay in aging includes improving the survival rate of naturally aging model organisms, delaying the decline in the survival rate of naturally aging model organisms, or extending their survival time during the natural aging process. The product in question is a drug, food, or cosmetic.

Citation Information

Patent Citations

  • Anti-aging sturgeon roe tetrapeptide as well as preparation method and application thereof

    CN117384245A